Home > Formulary : Adult > Recent Decisions > 2021 >
Decisions 19th October 2021
At the meeting on the 19th October, the following decisions were agreed
New Drug Requests
Approved
Aprepiptant (TLS Red)
- For prevention of post-operative nausea and vomiting for patients attending adult anti-reflux surgery
Toujeo Doublestar (TLS Amber no SCP)
- for patients requiring >80 units per dose
Shared Care Protocols/TLS Status
Updated SCPs
Mycophenolate SCP updated to include dermatology and oral mucosal indications
Testosterone for testosterone replacement for male hypogonadism
Further Work
Prasugrel to be approved as TLS Amber 1 month for interventional neuroradiology operations, such as stent assisted coiling and flow diverter treatment once SCP updated and approved
Sativex for multiple sclerosis related moderate to severe spasticity- further work is needed before inclusion to the formulary.